🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 52% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 tsp Serving Size
60 Servings
Other Combinations Product Type
52% Evidence Coverage

Supplement Facts — Evidence Check

Calories
25 {Calories}
Calories from Fat
15 {Calories}
Total Fat
1.5 Gram(s) (2% DV)
Saturated Fat
0.5 Gram(s) (3% DV)
Cholesterol
10 mg (3% DV)
Sodium
20 mg (1% DV)
Total Carbohydrates
2 Gram(s) (1% DV)
Sugar
1 Gram(s)
Vitamin A
1334 IU (27% DV)
Vitamin C
20 mg (33% DV)
100 IU (25% DV)
✅ Within RDA (0.2× RDA of 0.015 mg) 📚 604 studies (Tier A: 16, B: 251)
RDA 0.015mg This product: 0.0025mg UL 0.1mg
7.5 IU (25% DV)
✅ Within RDA (0.3× RDA of 15 mg) 📚 177 studies (Tier A: 3, B: 90)
RDA 15mg This product: 5.025mg UL 1000mg
0.7 mg (47% DV)
✅ Within RDA (0.6× RDA of 1.2 mg) 📚 76 studies (Tier A: 0, B: 33)
RDA 1.2mg This product: 0.7mg
0.8 mg (47% DV)
✅ Within RDA (0.6× RDA of 1.3 mg) 📚 12 studies (Tier A: 0, B: 1)
RDA 1.3mg This product: 0.8mg
9 mg (45% DV)
✅ Within RDA (0.6× RDA of 14 mg) 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 9mg UL 35mg
1 mg (50% DV)
✅ Within RDA (0.8× RDA of 1.3 mg) 📚 113 studies (Tier A: 3, B: 35)
RDA 1.3mg This product: 1mg UL 100mg
100 mcg (25% DV)
✅ Within RDA (0.2× RDA of 0.4 mg) 📚 225 studies (Tier A: 10, B: 105)
RDA 0.4mg This product: 0.1mg UL 1.0mg
0.5 mcg (8% DV)
✅ Within RDA (0.2× RDA of 0.0024 mg) 📚 138 studies (Tier A: 1, B: 44)
RDA 0.0024mg This product: 0.0005mg
75 mcg (25% DV)
✅ 2.5× RDA — within safe limits 📚 26 studies (Tier A: 0, B: 11)
RDA 0.03mg This product: 0.075mg
3 mg (30% DV)
✅ Within RDA (0.6× RDA of 5 mg) 📚 1 studies — no high-quality reviews
RDA 5mg This product: 3mg
📊 Market median: 750.0mg (447 products) 📚 388 studies (Tier A: 18, B: 204)
This product: 237.5mg UL 3000mg
📊 Market median: 750.0mg (447 products) 📚 388 studies (Tier A: 18, B: 204)
This product: 172.5mg UL 3000mg
📊 Market median: 750.0mg (447 products) 📚 388 studies (Tier A: 18, B: 204)
This product: 560mg UL 3000mg

Other Ingredients

concentrated Pineapple modified Corn Starch purified Water Fructose concentrated Orange Mango & Banana puree Hydroxypropyl Alginate Pineapple flavor Acacia Gum Mixed Tocopherols Vanilla flavor Sucralose Potassium Sorbate

Label Claims — Verification

All Other
All Other (99% of products) Structure/Function (86% of products) Nutrient (79% of products) Qualified Health (13% of products) Approved Health (2% of products)

Target Groups

Children 4 or More Years of Age Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Recommended intake: Adults and Adolescents (9 years and older): One teaspoon (5 ml) taken two times daily with a meal or as professionally directed. Children (4-8 years): One teaspoon (5 ml) taken daily with a meal or as professionally directed. Can be taken in water or juice or directly into the mouth.

⚠️ Warnings & Precautions

Keep out of reach of children.

Vacuum-sealed for your protection and for product freshness. Do not use if outer seal is missing or broken.

Additional Information

Independently tested for PCBs, dioxins and furans, PAHs and the absence of detectable levels of mercury and other heavy metals.

Refrigerate after opening.

Pack size:

Nutriceutical & Biophysical Systems

Seroyal

Code FA43-300

Product Details

UPC / SKU 883196 20360
DSLD Entry Date 2016-01-25
Product Type Other Combinations
Form Liquid
Brand Pharmax
DSLD ID 55787
Data Updated 2026-04-11

Research Evidence

495 Research Sources
56 Avg Quality Score
222 Meta Analysis
104 Clinical Trial
72 Rct
69 Systematic Review
11 Guideline
5 Cochrane Review
5 Regulatory Source
3 Narrative Review
1 Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
View all evidence for Omega 3 →

Compare Similar Products

View all Omega 3 products →